Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why Roth Capital Partners gives GameSquare a 'buy' rating

(Source: Roth Capital Partners) Click here to download Roth Capital Partners’ full report on GameSquare Holdings . This is third-party provided content issued on behalf of GameSquare Holdings Inc. (NDAQ:GAME) , please see full discl...

Analyst Raises Q3/19 Production Estimates Texas-Based Oil & Gas Company

The revisions and the reasons for them are discussed in a ROTH Capital Partners report. In an Aug. 27 research note, analyst John White reported that ROTH Capital Partners raised its Q3/19 production estimate for Lonestar Resources US Inc. (LONE:NASDAQ) , "based on g...

Improved Recovery Rate Spurs Target Price Increase on Gold Developer

The metallurgical result and its implications are addressed in a ROTH Capital Partners report. In an Aug. 14 research note, ROTH Capital Partners analyst Jake Sekelsy reported that the final results from the metallurgical work done at Vista Gold Corp.'s (VGZ:...

'Top Performer in the Precious Metals Space' Continues Run

Key Q2/19 financial metrics and upcoming catalysts are covered in a ROTH Capital Partners report. In a July 31 research note, ROTH Capital Partners analyst Jake Sekelsky reported that Kirkland Lake Gold Inc. (KL:TSX; KL:NYSE) "delivered another strong quart...

Producer Hits 'Major' Discovery, Target Price Raised

This new finding of SilverCrest Metals and its potential to improve the upcoming project feasibility study are described in a ROTH Capital Partners report. In a Feb. 18 research note, ROTH Capital Partners analyst Jake Sekelsky reported that SilverCrest Met...

Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment

The design, timeline and takeaways of Beyond Air's study are presented in a ROTH Capital Partners report. In a June 16 research note, ROTH Capital Partners analyst Scott Henry reported that Beyond Air Inc. (XAIR:NASDAQ) enrolled the first patient in its U.S. clin...

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...

STACK Agreement 'Positive' for Area Operator

The deal details are relayed in a ROTH Capital Partners report. In a Dec. 10 research note, ROTH Capital Partners analyst John White purported that a recent development in the industry is positive for Chaparral Energy Inc. (CHAP:NYSE) as its primary areas of operati...

Scoping Study for U.S. Lithium Project Confirms 'Robust Economics'

The pros and cons of the parameters outlined within it were addressed in a ROTH Capital Partners report. In an Aug. 8 research note, ROTH Capital Partners analyst Joe Reagor reported that Piedmont Lithium Ltd.'s (PLL:NASDAQ; PLL:ASX) updated scoping study for its No...

Clinical Trial Starts for Biopharma's Antifungal in Cryptococcal Meningitis

The details of this study and a second one are outlined in a ROTH Capital Partners report. In an Oct. 16 research note, ROTH Capital Partners analyst Jerry Isaacson reported that Matinas BioPharma Holdings Inc. (MTNB:NYSE.American) launched its first clinical trial ...
1 2 3 4 5